Richard K Fisher
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$1.8MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 8, 2025 | NSF | STTR Phase II STTR Phase II: Multifunctional Lipid Nanoparticle Delivery System for Targeted Delivery of Vascular RNA Therapeutics | $1.2M | ORION THERAPEUTICS INC. |
| Mar 15, 2023 | NSF | STTR Phase I STTR Phase I:Multifunctional Lipid Nanoparticle Delivery System for Targeted Delivery of Vascular RNA Therapeutics | $295K | Richard Fisher with The University of Tennessee, Memphis - The Health Science Center |
| Mar 10, 2023 | NSF | SBIR Phase I STTR Phase I: Multifunctional Lipid Nanoparticle Delivery System for Targeted Delivery of Vascular RNA Therapeutics | $295K | ORION THERAPEUTICS INC. |
Peer ranks
Federal funding#1,150
Awards as PI#822
Patents#273
Companies
- ORION THERAPEUTICS INC.Linked by awards · Biotech
- Richard FisherLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.